Free Trial

Avalon GloboCare (ALBT) Competitors

Avalon GloboCare logo
$2.29 +0.04 (+1.78%)
Closing price 10/21/2025 03:59 PM Eastern
Extended Trading
$2.28 -0.01 (-0.44%)
As of 06:55 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ALBT vs. TENX, XFOR, SCYX, ANVS, KZR, XCUR, AKTX, TAOX, RNTX, and IMA

Should you be buying Avalon GloboCare stock or one of its competitors? The main competitors of Avalon GloboCare include Tenax Therapeutics (TENX), X4 Pharmaceuticals (XFOR), SCYNEXIS (SCYX), Annovis Bio (ANVS), Kezar Life Sciences (KZR), Exicure (XCUR), Akari Therapeutics (AKTX), Synaptogenix (TAOX), Rein Therapeutics (RNTX), and ImageneBio (IMA). These companies are all part of the "pharmaceutical products" industry.

Avalon GloboCare vs. Its Competitors

Avalon GloboCare (NASDAQ:ALBT) and Tenax Therapeutics (NASDAQ:TENX) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, profitability, risk, media sentiment, valuation and earnings.

In the previous week, Tenax Therapeutics had 3 more articles in the media than Avalon GloboCare. MarketBeat recorded 3 mentions for Tenax Therapeutics and 0 mentions for Avalon GloboCare. Tenax Therapeutics' average media sentiment score of 0.00 beat Avalon GloboCare's score of 0.00 indicating that Tenax Therapeutics is being referred to more favorably in the news media.

Company Overall Sentiment
Avalon GloboCare Neutral
Tenax Therapeutics Neutral

1.4% of Avalon GloboCare shares are owned by institutional investors. Comparatively, 1.7% of Tenax Therapeutics shares are owned by institutional investors. 37.3% of Avalon GloboCare shares are owned by insiders. Comparatively, 3.7% of Tenax Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Tenax Therapeutics has a net margin of 0.00% compared to Avalon GloboCare's net margin of -1,451.94%. Avalon GloboCare's return on equity of 0.00% beat Tenax Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Avalon GloboCare-1,451.94% N/A -75.12%
Tenax Therapeutics N/A -31.34%-30.39%

Tenax Therapeutics has a consensus price target of $18.00, suggesting a potential upside of 149.31%. Given Tenax Therapeutics' stronger consensus rating and higher possible upside, analysts clearly believe Tenax Therapeutics is more favorable than Avalon GloboCare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Avalon GloboCare
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Tenax Therapeutics
1 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.83

Avalon GloboCare has higher revenue and earnings than Tenax Therapeutics. Tenax Therapeutics is trading at a lower price-to-earnings ratio than Avalon GloboCare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Avalon GloboCare$1.33M6.61-$7.90M-$19.96-0.11
Tenax TherapeuticsN/AN/A-$17.60M-$0.92-7.85

Avalon GloboCare has a beta of 0.03, indicating that its share price is 97% less volatile than the S&P 500. Comparatively, Tenax Therapeutics has a beta of 1.58, indicating that its share price is 58% more volatile than the S&P 500.

Summary

Tenax Therapeutics beats Avalon GloboCare on 11 of the 16 factors compared between the two stocks.

Get Avalon GloboCare News Delivered to You Automatically

Sign up to receive the latest news and ratings for ALBT and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ALBT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ALBT vs. The Competition

MetricAvalon GloboCareMED IndustryMedical SectorNASDAQ Exchange
Market Cap$8.63M$3.47B$6.22B$10.67B
Dividend YieldN/A2.27%5.74%4.88%
P/E Ratio-0.1123.0629.1527.23
Price / Sales6.61494.28589.23132.71
Price / CashN/A47.5937.5161.65
Price / Book-0.2010.6612.386.59
Net Income-$7.90M-$52.56M$3.32B$276.14M
7 Day Performance2.23%2.64%0.75%-0.72%
1 Month Performance-16.12%13.86%7.29%2.47%
1 Year Performance-22.90%14.85%62.62%33.90%

Avalon GloboCare Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ALBT
Avalon GloboCare
0.9424 of 5 stars
$2.29
+1.8%
N/A-23.7%$8.63M$1.33M-0.115
TENX
Tenax Therapeutics
2.0573 of 5 stars
$7.47
+0.8%
$18.00
+141.0%
+78.3%$34.06MN/A-8.129Short Interest ↑
XFOR
X4 Pharmaceuticals
3.9847 of 5 stars
$2.96
-3.3%
$34.17
+1,054.3%
-78.9%$33.89M$2.56M-0.2080
SCYX
SCYNEXIS
0.7264 of 5 stars
$0.80
-1.1%
N/A-48.7%$33.28M$3.75M-1.9860Short Interest ↑
High Trading Volume
ANVS
Annovis Bio
3.3218 of 5 stars
$1.70
+2.1%
$17.33
+922.6%
-77.5%$33.13MN/A-0.833
KZR
Kezar Life Sciences
2.6456 of 5 stars
$4.40
+2.4%
$9.00
+104.8%
-21.4%$32.17M$7M-0.4560
XCUR
Exicure
1.2183 of 5 stars
$5.08
-1.3%
N/A+77.5%$32.07M$500K-1.3150News Coverage
AKTX
Akari Therapeutics
2.6939 of 5 stars
$0.96
+2.2%
$3.30
+242.7%
-65.2%$31.41MN/A0.009Short Interest ↑
TAOX
Synaptogenix
0.0809 of 5 stars
$8.95
-6.2%
N/AN/A$31.24MN/A-0.444Gap Up
RNTX
Rein Therapeutics
2.6564 of 5 stars
$1.33
+0.8%
$10.00
+651.9%
N/A$31.00MN/A-0.499
IMA
ImageneBio
2.8655 of 5 stars
$7.64
-0.7%
$35.50
+364.7%
-63.1%$30.64M$9.16M-0.9970Negative News
Short Interest ↑

Related Companies and Tools


This page (NASDAQ:ALBT) was last updated on 10/22/2025 by MarketBeat.com Staff
From Our Partners